300878 维康药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.767-0.5773.4926.94614.290
总资产报酬率 ROA (%)1.286-0.4062.7065.80910.845
投入资产回报率 ROIC (%)1.415-0.4453.0016.6189.503

边际利润分析
销售毛利率 (%)48.92450.39458.85467.71172.475
营业利润率 (%)13.320-0.19512.18015.66325.537
息税前利润/营业总收入 (%)13.6570.34212.48515.32424.631
净利润/营业总收入 (%)12.198-1.1909.29315.25321.791

收益指标分析
经营活动净收益/利润总额(%)98.913699.01360.84095.03485.834
价值变动净收益/利润总额(%)13.046-318.57723.4180.2640.000
营业外收支净额/利润总额(%)-1.07482.483-2.6940.886-0.212

偿债能力分析
流动比率 (X)5.4832.4002.5033.7444.674
速动比率 (X)4.5272.0432.2203.1874.289
资产负债率 (%)20.44631.23326.29816.78915.005
带息债务/全部投入资本 (%)10.19322.12816.9273.468--
股东权益/带息债务 (%)847.163337.814471.5422,683.57744,554.298
股东权益/负债合计 (%)383.836217.420277.632491.521565.176
利息保障倍数 (X)28.5360.23519.990-31.993-28.897

营运能力分析
应收账款周转天数 (天)110.706167.576218.148187.3830.000
存货周转天数 (天)122.113188.939202.341186.5370.000